You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 22 No. 1, January 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Benign Intracranial Hypertension Associated With Hypervitaminosis A

Martin H. Feldman, MD; Nathan S. Schlezinger, MD

Arch Neurol. 1970;22(1):1-7.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MANY explanations have been proposed concerning the etiology of benign intracranial hypertension (BIH).1-109 The syndrome includes headache, papilledema, increased intracranial pressure, and occasional related visual field defects and sixth nerve palsies.1-10 The patients are alert, and the electroen-cephalogram is usually normal,11 as are the cerebrospinal fluid (CSF) protein level and cell count. Pneumoencephalogram shows a normal or small ventricular system, and no obstruction of extracerebral CSF patterns.1-7 Brain edema has been noted on biopsy, with swelling of all cellular elements.12 Papilledema can occasionally be so severe as to constitute a threat to vision.7 The majority of patients experience a self-limiting course, with rare recurrence.13

Implicated as causative factors have been the following: (1) obstruction or impairment of intracranial venous drainage7,14-28; (2) endocrine and metabolic dysfunctions,29-43 including obesity,30-33 menstrual disorders,34,35 pregnancy,36,37 menarche,38 Addison's disease,39 and hypoparathy-roidism40-42; (3) exogenously administered drugs,44-62 including adrenal steroids,44-51 female sex hormones,52-54 antibiotics,55-61 and psychotherapeutic drugs62; and . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

From the Jefferson Medical College Hospital, Philadelphia. Dr. Feldman is now at the Department of Anatomy, Albert Einstein College of Medicine, Bronx, NY.


Footnotes

Submitted for publication Aug 25, 1969; accepted Sept 12.

Read in part before the Philadelphia Neurological Society, April 8, 1966.

Reprint requests to the Department of Neurology, Jefferson Medical College Hospital, Philadelphia 19107 (Dr. Schlezinger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.